Alert detail

LCD L38972: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer — Noridian

Policy ID: LCD-L38972Specialty: OncologyAdded: 6/5/2026Effective: 2026-02-05lcd
Routine

Full alert analysis requires a subscription

Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.